Dr. Amy Searight is a leading U.S. expert on Southeast Asia and U.S. policy in the Indo-Pacific region. Dr. Searight served as Deputy Assistant Secretary of Defense for South and Southeast Asia from 2014 to 2016, before which she served in the Office of the Secretary of Defense, USAID, and on the State Department’s Policy Planning Staff. Today, Amy is a senior associate for Asia at CSIS. On this episode, Amy offered a preview of the historic U.S.-ASEAN Special Summit, which U.S. President Joe Biden will host in Washington on May 12-13. In addition to expectations for the summit, we discussed the challenges facing ASEAN, its members’ views on the U.S. Indo-Pacific Strategy and economic framework, China’s relations with the bloc, the Philippines election, and more.
Podcasts
Dr. Amy Searight on the Issues Driving the 2022 U.S.-ASEAN Summit
- ASEAN, United States
Recent Posts
Han Lin in The Straits Times: announcement of nuclear weapons testing at the Trump-Xi meeting was “bold and disruptive.’
October 31, 2025
Media Mentions
TAG China Country Director Han Lin noted, “He’s forcing the room to focus on US leverage amid the smiles. If ...
Han Lin in The Globe and Mail: Trump-Xi meeting ‘more of a tactical pause than strategic breakthrough.’
October 30, 2025
Media Mentions
TAG China Country Director Han Lin noted, “Yet though the core issues of the U.S.-China rivalry – such as technology ...
Alison Szalwinski in DW: ‘Washington’s tumultuous trade negotiations — from China to India to Korea — have left many of its Asian allies questioning whether the United States still sees economic integration as a strategic asset or a bargaining chip.’
October 30, 2025
Media Mentions
Szalwinski from The Asia Group said that countries have been hedging for some time by “doubling down on smaller, results-oriented ...
Han Lin in CNBC: ‘The U.S. decision to cut fentanyl-related tariffs to 10% addresses a key Chinese grievance.’
October 30, 2025
Media Mentions
TAG China Country Director Han Lin shared that “Beijing’s efforts to curb exports of fentanyl precursors, long unrecognized by Washington, ...